Lawrence P. Wennogle, Vice President, Drug Discovery at Intra-Cellular Therapies, Inc. (ITCI), sold 5,000 shares at $15.00 ($75K) on 2014-09-15, disclosed to the SEC on 2014-09-17.
Scheduled sale ($75k) by Vice President, Drug Discovery under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ITCI | SELL | 2014-10-15 | $54K | — | Filing → |
| ITCI | SELL | 2014-10-10 | $71K | — | Filing → |
| ITCI | SELL | 2014-10-07 | $247K | — | Filing → |